JPRN-UMIN000045317Completed未知
A study of immunity - A study of immunity
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- EP Mediate Co., Ltd.
- Enrollment
- 64
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 65years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •(1) Subjects who were unaware of cold or cold-like symptoms (2) Subjects who are taking drugs or quasi-drugs, supplements (3) Subjects who have a history of the allergic disease (4) Subjects who have under treatment or a history of serious disease (5) Subjects who have oral or dental problems (6) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination (7) Subjects who are engaged in day / night shift work or midnight work, etc. (8) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study (9) Subjects who intend to become pregnant or lactating (10) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (11) Subjects who are judged as unsuitable for the study by the investigator
Investigators
Similar Trials
Completed
Not Applicable
Observational study on the acquisition of immunity in convalescent people with Novel Coronavirus(COVID-19) infectioSARS-CoV-2 infectionJPRN-UMIN000044638Medical Corporation Tsurukamekai Shinjuku Tsurukame Clinic100
Completed
Unknown
A study for evaluating the immune response by ingestion of fermented plant extractHealthy adultJPRN-UMIN000052021EP Mediate Co., Ltd.36
Completed
Not Applicable
A study for evaluating the immune response by ingestion of a fucoidan-containing food in adult males and females : a randomized, double blind, placebo-controlled, parallel-group trialJPRN-UMIN000024995TTC Co., Ltd.60
Completed
Phase 4
Influenza Specific Immunity After Vaccination in Recipients of Haematopoietic Stem Cell Transplantation Compared to Healthy ControlsHaematopoietic Stem Cell Transplant patientshaematological malignancyAutologous or allogeneicCancer - Any cancerInfection - Other infectious diseasesInflammatory and Immune System - Other inflammatory or immune system disorderscancerInfluenzaACTRN12614000240640Princess Margaret Hospital for children150
Completed
Not Applicable
A prospective observational study of immune-related adverse events, treatment efficacy, and pre-existing autoantibodies in patients with small-cell lung cancer who was treated by immune checkpoint inhibitorPatients with small cell lung cancer who was treated by chemotherapy plus immune checkpoint inhibitor as first line therapyJPRN-UMIN000042962Kobe City Medical Center General Hospital Respiratory Medicine54